The NHS will offer a once-daily triple therapy for cystic fibrosis to hundreds more patients, including those with rare ...

In July 2025, Vertex Pharmaceuticals Incorporated conducted a study is to evaluate the pharmacokinetics, safety, tolerability ...

Vertex Pharmaceuticals received a boost with Canada's approval of ALYFTREK for cystic fibrosis. This approval boosts sentiment. The stock saw a 7% rise over the past month amid broader market optimism ...

Vertex Pharmaceuticals has solidified its leadership in the cystic fibrosis (CF) market through strategic innovation and ...

Vertex Pharmaceuticals (VRTX) received a significant boost as Health Canada's approval of ALYFTREK marked a vital step in expanding cystic fibrosis treatment options. This approval and other successes ...

It said that 95% of people with cystic fibrosis in England will now be eligible for modulator therapy. The new drug, also ...

About a third of lung transplant patients with cystic fibrosis receive elexacaftor-tezacaftor-ivacaftor; use is higher among ...

POW Collision CARSTAR team members rolled up their sleeves and grabbed the soap to wash cars for a good cause on July 17: Supporting people affected by cystic ...

Narrabri West Public School celebrated Crazy Hair Day raising $202 for cystic fibrosis research, which is a cause very close to their hearts here at the school. The money used for cystic fibrosis ...

Coa charity event in Fermanagh raises £3,109 for Cystic Fibrosis, celebrating Hannah Harte’s 30th birthday with music and ...

Importantly, treatment of patients with cystic fibrosis with the natural serine protease inhibitor α1-antitrypsin for 4 weeks reduced the levels of free elastase in their lungs, increased the ...

Cystic fibrosis (CF) is the most common life-limiting inherited disease among individuals of white ancestry. 1–3 The CF Foundation estimates that there are 30,000 individuals affected with CF in ...